Abstract
The European Bifurcation Club (EBC) supports a continuous review of the field of coronary artery bifurcation interventions and aims to facilitate a scientific discussion and an exchange of ideas on the management of bifurcation disease. The recent focus of meetings and consensus statements has been on the technical issues in bifurcation stenting, recognising that the final result of a bifurcation procedure and the long-term outcome for our patients are strongly influenced by factors, including preprocedural strategy, stenting technique selection, performance of optimal procedural steps, the ability to identify and correct complications and finally, and most important, the overall performance of the operator. Continuous refinement of bifurcation stenting techniques and the promotion of education and training in bifurcation stenting techniques represent a major clinical need. Accordingly, the consensus from the latest EBC meeting in Brussels, October 2021, was to promote education and training in bifurcation stenting based on the EBC principle. Part II of this 16th EBC consensus document aims to provide a step-by-step overview of the pitfalls and technical troubleshooting during the implantation of the second stent either in the provisional stenting (PS) strategy or in upfront 2-stent techniques (e.g., 2-stent PS pathway and double kissing crush stenting). Finally, a detailed overview and discussion of the numerous modalities available to provide continuous education and technical training in bifurcation stenting techniques are discussed, with consideration of their future application in enhancing training and practice in coronary bifurcation lesion treatment.
Original language | English |
---|---|
Pages (from-to) | 457-470 |
Number of pages | 14 |
Journal | Eurointervention |
Volume | 18 |
Issue number | 6 |
Early online date | 15 May 2022 |
DOIs | |
Publication status | E-pub ahead of print - 15 May 2022 |
Bibliographical note
Funding Information:J.F. Lassen has received speaker fees from Medtronic, Boston Scientific, Biotronik, Abbott, and Biosensors. R. Albiero has received speaker fees from Medtronic, and Abbott. T.W. Johnson has received speaker fees from Abbott, Boston Scientific, Medtronic, and Terumo and institutional funding for fellowships from Boston Scientific, and Terumo. F. Burzotta has received speaker fees from Medtronic, Abiomed, Abbott, and Terumo. T. Lefèvre has received speaker or proctorship fees from Abbott, Boston Scientific, Terumo, and Edwards Lifesciences. M. Pan has received speaker fees from Abbott, Terumo, and Volcano. A.P. Banning declares institutional funding of a fellowship from Boston Scientific and has received speaker fees from Boston Scientific, Abbott, Medtronic, Philips/ Volcano, and Miracor. Y.S. Chatzizisis has received speaker fees/ consultancy/research funding from Boston Scientific, and Medtronic. O. Darremont has received speaker fees from Edwards Lifesciences. D. Hildick-Smith has received advisory board/consultancy/research funding from Terumo, Medtronic, Abbott, and Boston Scientific. G. Stankovic has received speaker fees from Medtronic, Abbott, Boston Scientific, and Terumo. The other authors have no conflicts of interest to declare.
Publisher Copyright:
© EuroIntervention.All rights reserved.